BIO-KEY INTERNATIONAL INC (BKYI)
NASDAQIndustrialsInformation Technology ServicesSnapshot 2026-09-04
$2.81-0.35%
Close 2026-09-04 · 1-day change
NASDAQIndustrialsInformation Technology ServicesSnapshot 2026-09-04
QuarterlyIQ Insights · BKYI
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 | FY 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||||||||||
| Revenues | 6.7 | 5.9 | 6.9 | 7.8 | 7.0 | 5.1 | 2.8 | 2.3 | 4.0 | 6.3 | 3.0 | 5.3 | 4.0 | 2.0 | 3.8 | 3.5 |
| Total Revenues | — | — | — | — | — | — | — | — | — | 6.3 | 3.0 | 5.3 | 4.0 | 2.0 | 3.8 | 3.5 |
| Cost of Revenues | 1.3 | 1.4 | 1.3 | 6.3 | 2.4 | 1.7 | 0.8 | 2.5 | 4.2 | 3.2 | 0.7 | 1.3 | 0.7 | 0.4 | 0.6 | 0.8 |
| Gross Profit | 5.4 | 4.6 | 5.6 | 1.4 | 4.6 | 3.4 | 2.0 | (0.2) | (0.1) | 3.1 | 2.2 | 4.0 | 3.3 | 1.6 | 3.3 | 2.7 |
| Operating Expenses & Income | ||||||||||||||||
| Selling, General & Admin | 6.1 | 6.3 | 7.1 | 7.9 | 9.4 | 6.0 | 5.8 | 5.0 | 5.3 | 5.7 | 4.4 | 4.1 | 3.7 | 2.8 | 2.3 | 3.0 |
| R&D Expenses | 2.6 | 2.6 | 2.5 | 2.4 | 3.3 | 2.4 | 1.4 | 1.3 | 1.4 | 1.7 | 2.0 | 1.6 | 1.6 | 1.3 | 0.9 | 1.1 |
| Operating Income | (5.8) | (6.8) | (4.0) | (8.8) | (9.9) | (4.9) | (5.2) | (1.1) | 0.0 | (4.3) | (4.2) | (1.7) | (2.0) | (2.5) | 0.0 | (1.5) |
| Earnings from Continuing Operations | ||||||||||||||||
| Interest Expense | — | 0.1 | 0.2 | 0.2 | 0.0 | 0.0 | 4.3 | 1.1 | — | — | 0.2 | 0.2 | 0.1 | 0.1 | 0.0 | 0.4 |
| Interest & Investment Income | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | — | — | — | 0.0 | 0.0 | 0.0 | 0.1 |
| Net Interest Expenses | — | — | — | 0.2 | 0.0 | 0.0 | 4.3 | 1.1 | — | — | — | — | 0.1 | 0.1 | 0.0 | 0.3 |
| Other Non-Operating Income / Expenses | (0.2) | (0.3) | (0.3) | 0.2 | (2.0) | (0.1) | (4.5) | (13.5) | — | 0.0 | — | (0.2) | 0.2 | (0.1) | (0.0) | (0.4) |
| Asset Writedown | — | 2.5 | — | — | — | — | — | — | 0.0 | — | — | — | — | — | — | — |
| EBT, Incl. Unusual Items | (6.0) | (7.1) | (4.3) | (8.7) | (11.9) | 0.0 | — | — | — | — | — | — | — | — | — | — |
| Income Tax Expense | — | 0.0 | (0.0) | (0.1) | (0.0) | 0.0 | 0.0 | 0.0 | 0.0 | — | (0.0) | 0.2 | 0.0 | 0.0 | 0.0 | 0.0 |
| Net Income | ||||||||||||||||
| Net Income | 8.3 | (7.2) | (4.3) | (8.5) | (11.9) | (5.1) | (9.7) | (14.6) | (6.9) | (4.3) | (4.2) | (1.9) | (1.9) | (2.6) | 0.0 | (1.9) |
| Per Share | ||||||||||||||||
| Basic EPS | 7.98 | (10.77) | (2.09) | (15.21) | (27.26) | (0.65) | — | — | — | — | — | — | — | — | — | — |
| Basic Weighted Avg Shares | 1.0 | 0.7 | 2.1 | 0.6 | 0.4 | 7.8 | — | — | — | — | — | — | — | — | — | — |
| Supplemental | ||||||||||||||||
| EBITDA | — | (6.7) | (3.9) | (8.8) | (9.9) | — | — | — | — | — | — | (1.7) | (2.0) | (2.5) | 0.1 | — |
| EBIT | (5.8) | (6.8) | (4.0) | (8.8) | (9.9) | (4.9) | (5.2) | (1.1) | 0.0 | (4.3) | (4.2) | (1.7) | (2.0) | (2.5) | 0.0 | (1.5) |
| Effective Tax Rate | — | — | — | 1.5% | 0.2% | — | — | — | — | — | — | — | — | — | — | — |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.